BONE DENSITY SURVEY AND ASSOCIATED FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT 19-8 HOSPITAL

Thị Nhớ Bạch 1,, Thị Tô Châu Trần2, Thị Việt Hà Đặng3
1 19-8 hospital
2 Musculoskeletal Center - Bach Mai Hospital
3 Center for Kidney, Urology and Dialysis - Bach Mai Hospital

Main Article Content

Abstract

Objective: Describe the bone density characteristics of patients with stage 3-5 chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing hemodialysis at 19-8 Hospital.Study Population and Methods: A cross-sectional descriptive study was conducted on 152 CKD patients, divided into two groups: 93 CKD patients in stages 3-5 who had not received renal replacement therapy, and 59 ESRD patients undergoing cyclical hemodialysis at 19-8 Hospital. Blood samples were collected from all patients for laboratory testing, and bone density measurements were taken at the lumbar spine, femoral neck, and total hip using Dual-Energy X-ray Absorptiometry (DEXA) method. Results: In the group of 93 CKD patients in stages 3-5 (female: 22.6%, male: 77.4%), the mean age was 67.71±15.0344 years. The average bone density measurements were as follows: lumbar spine (1.0939±0.213 g/cm2), total hip (0.8591±0.256 g/cm2), and femoral neck (0.7679±0.166 g/cm2). The prevalence of osteoporosis was 31.2%, and the proportion of decreased bone density was 39.8%. In the group of 59 ESRD patients undergoing cyclical hemodialysis (female: 33.9%, male: 66.1%), the mean age was 52±14.1446 years. The average bone density measurements were as follows: lumbar spine (1.072±0.167 g/cm2), total hip (0.8178±0.131g/cm3), and femoral neck (0.7457±0.127 g/cm3). The prevalence of osteoporosis was 28.8%, and the proportion of decreased bone density was 50.8%.

Article Details

References

1. Nguyễn Thị Ngọc Lan. Loãng xương. Bệnh học nội khoa tập II, nhà xuất bản y học Hà Nội. 2018: 205-210.
2. Nguyễn Văn Thanh. Nghiên cứu mật độ xương và một số yếu tố liên quan ở bệnh nhân suy thận mạn chưa điều trị thay thế, luận văn tốt nghiệp Bác sĩ nội trú, Trường Đại học Y Hà Nội.2009.
3. Nguyễn Minh thủy. Nghiên cứu mật độ xương ở bệnh nhân suy thận mạn từ 50 tuổi trở lên và một số yếu tố liên quan, luận văn thạc sĩ Y học, Trường Đại học Y Hà Nội. 2010.
4. Malluche H, Faugere M-C. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney International. 1990;38(2):193-211. doi:10.1038/ki.1990.187
5. Malluche HH. Renal bone disease--an ongoing challenge to the nephrologist. Clin Nephrol. 1995;44 Suppl 1: S38-41.
6. International Society of Nephrology (2009), "KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease- mineral and bone disorders (CKD-MBD)",
Kidney International Supplements. 76.
7. International society of nephrology (2017), "KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKDMBD)", Kidney International Supplements. 7, pp. 1-59.
8. Jamal SA, Cheung AM, West SL, Lok CE. Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int. 2012;23(12):2805-2813. doi:10.1007/s00198-012-1908-y
9. Fernandez-Martin, J. L., et al. (2013), "COSMOS: the dialysis scenario of CKD-MBD in Europe", Nephrol Dial Transplant. 28(7), pp. 1922-1935
10. Nguyễn Hoàng Thanh Vân (2015), Nghiên cứu nồng độ betacrosslaps, hormon tuyến cận giáp huyết thanh ở bệnh nhân bệnh thận mạn giai đoạn cuối, Luận án tiến sĩ y học, Đại học Y Dược Huế